"10.1371_journal.pone.0099590","plos one","2014-06-18T00:00:00Z","Annika √Ölgars; Tuulia Avoranta; Pia √ñsterlund; Minnamaija Lintunen; Jari Sundstr√∂m; Terhi Jokilehto; Ari Ristim√§ki; Raija Ristam√§ki; Olli Carp√©n","Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland; Department of Oncology, University of Helsinki, Helsinki, Finland; Department of Pathology, University of Turku, Turku, Finland; Department of Pathology, Turku University Hospital ‚ÄTyks-Sapa, Turku, Finland; Division of Pathology and Genetics, Helsinki University Central Hospital - HUSLAB, Helsinki, Finland; Department of Pathology, Haartman Institute and Genome-Scale Biology, Research Programs Unit, University of Helsinki, Helsinki, Finland","Conceived and designed the experiments: A√Ö TA P√ñ ML JS TJ AR RR OC. Performed the experiments: ML JS TJ. Analyzed the data: A√Ö TA P√ñ ML JS TJ AR RR OC. Contributed reagents/materials/analysis tools: A√Ö TA P√ñ ML JS TJ AR RR OC. Wrote the paper: A√Ö TA P√ñ ML JS TJ AR RR OC.","A√Ö, ML, JS, RR and OC are inventors in a patent related to this work: US 20110217296 A1 Method for selecting patients for treatment with an EGFR inhibitor. All remaining authors have declared no conflicts of interest. This does not alter the authors‚Äô adherence to PLOS ONE policies on sharing data and materials.","2014","06","Annika √Ölgars","A√",9,TRUE,9,3,9,9,FALSE,FALSE,TRUE,2,"1;3",TRUE
